Seòmar agus comataidhean

We recognise the distress and pain that migraines cause and we take the issue of migraine seriously.

The Centre for Sustainable Delivery launched the national headache pathway in October 2023, to improve care for migraines and headache across Scotland. The pathway is being implemented to aid with the diagnosis and management of headache disorders including migraine, offer guidance on management, and support health boards to aid their future planning.

Additionally, NES Pharmacy hosted a webinar in September 2024 to provide guidance to pharmacy staff on the assessment, support and management of people living with migraine in line with the Scottish National Headache Pathway.

We recognise the distress and pain that migraines cause and we take the issue of migraine seriously.

The Scottish Government funded £221,176 to the Migraine Trust across 2022-2024 to work upskilling community, primary and secondary care pharmacists across NHS Grampian to help people with migraine manage their condition more effectively. This included funding to partner other health boards to extend the reach of this model and increase care and support for people living with migraine.

An eLearning programme for NHS Education for Scotland’s (NES) platform TURAS was developed through the project, comprising a suite of training materials available for all pharmacists and pharmacy teams in Scotland to access.

The Scottish Stroke Improvement Programme plays an important role in driving forward improvements in Stroke care, including thrombolysis, throughout Scotland. Regular reviews are held with the stroke services in every NHS Board, and improvements in thrombolysis and reasons for variations in performance are discussed at these meetings. We continue to expect Health Boards to work to improve their standards of care locally.

A dedicated thrombolysis improvement event has been arranged for 8 October. This will allow medical and nursing representatives from all NHS Boards to share good practice, assess reasons for disparities in thrombolysis performance and agree approaches to clinical improvement.

The Scottish Government has made no specific estimate of the economic impact of migraine on Scotland’s economy and workforce productivity, however information regarding the impact of migraine on workplaces and the economy has been published by organisations such as the Migraine Trust.

We are working to support people with health conditions, such as migraine, to play an active role within the economy. We are investing up to £90 million in 2025-26 for the delivery of devolved employability services, providing intensive and personalised pre-employment and in-work support for unemployed people with barriers to progressing within work, including disabled people and with those with health conditions.

The Scottish Government does not know at this juncture what the rolling out of Jess’s Rule will require in terms of implementation either by GPs or NHS England. We will be in a position to consider the benefits of the rule when we know more.

However, the Scottish Government understands that the RCGP learning resource which supports “Jess’s Rule” is available to GPs who are members in Scotland as well as in England. We would encourage GPs to make use of this resource.

The provision of healthcare services is the responsibility of NHS boards. We expect all boards to ensure that their services are informed by current clinical best practice. In commissioning boards’ plans for the recently announced £4.5 million a year in funding for ME/CFS, long-COVID and other similar conditions, we have stressed the importance of ensuring that services are informed by current clinical best practice, such as National Institute for Excellence in Healthcare (NICE) guidelines NG:206 and NG:188- which are available to clinicians across the UK.

The Scottish Government does not know at this juncture, what the rolling out of Jess’s Rule will require in terms of implementation either by GPs or NHS England or what the impact will be for patients. We will monitor the implementation by NHS England.

Penalty clauses are not enforceable in Scots law and, as such, there are no penalties in the R100 Contracts.

However, Openreach is only paid for build once it has been completed and figures have been audited. This action incentivises Openreach to build as quickly as possible.

We are currently working with all NHS Health Boards to identify investment priorities across Scotland, that includes NHS Greater Glasgow and Clyde.

Historic real terms cuts to our block grant from the UK Government have put pressure on our capital budget and we have only recently received clarity from the UK Treasury for our capital and FT funding up to 2029-30.

As part of our own Scottish Spending Review, we are undertaking a full review of our capital spending to prioritise available funding towards projects that drive progress against our priorities. We will provide clarity over which projects will receive funding in the medium term when we publish this review, alongside our new Infrastructure Pipeline.

A commitment to a round-the-clock thrombectomy service was set out in our Stroke Improvement Plan and this remains our aim for the thrombectomy service.

Work is ongoing to align the governance and delivery of thrombectomy with similar national programmes. This alignment with wider health service planning aims to support oversight of thrombectomy planning, for the NHS Chief Executive Group and encourage greater collaboration between NHS Boards in delivering this vital service.

This work will inform the future expansion of the service, including angiography capacity, and will support consistency across thrombectomy services in Scotland, ensuring the service maximises use of existing resources.